JO
LIPO

John Overdeck’s Lipella Pharmaceuticals LIPO Stock Holding History

John Overdeck’s Portfolio LIPO Stock Details LIPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,623
Closed -$5.84K – 3241
2024
Q2 		$5.84K Sell
1,623
-12
-0.7% -$65 ﹤0.01% 2974
2024
Q1 		$8.96K Sell
1,635
-348
-18% -$2.59K ﹤0.01% 2957
2023
Q4 		$16.2K Buy
+1,983
New +$18.5K ﹤0.01% 3058

Other funds holding LIPO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

John Overdeck's LIPO Position: Q3 2024 in Review

John Overdeck sold out of Lipella Pharmaceuticals (LIPO) in Q3 2024, closing a stake of 1,623 shares — an estimated $5.84K sold.

John Overdeck first reported a position in LIPO in Q4 2023 and held it in 3 quarters. The position peaked at $16.2K in Q4 2023. 5 funds tracked by Wall St. Rank hold LIPO as of Q3 2024.

  • John Overdeck reported no remaining Lipella Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • John Overdeck sold 1,623 Lipella Pharmaceuticals shares in Q3 2024, an estimated $5.84K.
  • John Overdeck first reported a position in Lipella Pharmaceuticals in Q4 2023 and held it in 3 quarters.
  • John Overdeck's Lipella Pharmaceuticals position peaked at $16.2K in Q4 2023.
  • 5 funds tracked by Wall St. Rank held Lipella Pharmaceuticals as of Q3 2024.

Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.